Bionor Pharma ASA (OSE:BIONOR) will announce its fourth quarter 2014 results Wednesday 25 February 2015 at 7.00 CET.

The quarterly report and presentation will be available at the Company's website at this time www.bionorpharma.com. Presentation of the quarterly results by CEO David H. Solomon and CFO Synne Røine will be webcasted at 08.30.

Schedule for the webcast /teleconference 25 February
08.25 - Log in to the webcast-link, and/or use conference call numbers
08.30 - Review of results by Bionor Pharma CEO David H. Solomon and CFO Synne Røine

The webcast will be available at http://edge.media-server.com/m/p/h9qzm5ds

Conference Call numbers
Use the following numbers to participate in the Q&A session at the end of the presentation or listen to thewebcast by telephone:
Participants, Local - Oslo, Norway: +47 2350 0485
Participants, Local - London, United Kingdom: +44(0)20 3427 1922
Participants, Local - New York, United States of America: +1 646 254 3376
Participants, Local - Copenhagen, Denmark: +45 32 71 16 63
Participants, Local - Stockholm, Sweden: +46(0)8 5065 3935
Confirmation Code: 3261175
Participants will have to quote the above code when dialling into the conference.

One week replay - conference call replay numbers

Webcast is available for replay at the following numbers:
Local - Copenhagen, Denmark: 32 71 09 13
Local - London, United Kingdom: (0)20 3427 0598
Local - New York, United States of America: 347 366 9565
Local - Oslo, Norway: 2100 0498
Local - Stockholm, Sweden: (0)8 5051 3897
Replay Pass code: 3261175

Bionor Pharma ASA
Synne Røine
CFO
Tel +47 99 22 98 92

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian SecuritiesTrading Act

distributed by